Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter N Dimitrov

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
American Journal of Ophthalmology|July 2, 2003
Incidence and progression of cataract in the Melbourne Visual Impairment ProjectCatherine Anne McCarty, Bickol Nanjan Mukesh, Peter N Dimitrov, et al.
Investigative Ophthalmology & Visual Science|November 26, 2003
Five-year incidence of bilateral cause-specific visual impairment in the Melbourne Visual Impairment ProjectPeter N Dimitrov, Bickol N Mukesh, Catherine A McCarty, et al.
Ophthalmology|July 8, 2010
C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progressionLuba Robman, Paul N Baird, Peter N Dimitrov, et al.
Investigative Ophthalmology & Visual Science|January 4, 2008
Measuring rod and cone dynamics in age-related maculopathyPeter N Dimitrov, Robyn H Guymer, Andrew J Zele, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 13, 2006
Development of cataract and associated risk factors: the Visual Impairment ProjectBickol N Mukesh, Anhchuong Le, Peter N Dimitrov, et al.
Investigative Ophthalmology & Visual Science|February 1, 2014
Assessing residual visual function in severe vision lossLauren N Ayton, Nicholas V Apollo, Mary Varsamidis, et al.
Clinical & Experimental Ophthalmology|December 4, 2003
Iris colour, ethnic origin and progression of age-related macular degenerationCaroline M Nicolas, Luba D Robman, Gabriella Tikellis, et al.
Clinical Interventions in Aging|November 6, 2008
Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS)Robyn H Guymer, Peter N Dimitrov, Mary Varsamidis, et al.
Ophthalmology|June 5, 2004
Five-year incidence of age-related maculopathy: the Visual Impairment ProjectBickol N Mukesh, Peter N Dimitrov, Sophia Leikin, et al.
Investigative Ophthalmology & Visual Science|October 18, 2011
Visual function tests as potential biomarkers in age-related macular degenerationPeter N Dimitrov, Liubov D Robman, Mary Varsamidis, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
American Journal of Ophthalmology|July 2, 2003
Incidence and progression of cataract in the Melbourne Visual Impairment ProjectCatherine Anne McCarty, Bickol Nanjan Mukesh, Peter N Dimitrov, et al.
Investigative Ophthalmology & Visual Science|November 26, 2003
Five-year incidence of bilateral cause-specific visual impairment in the Melbourne Visual Impairment ProjectPeter N Dimitrov, Bickol N Mukesh, Catherine A McCarty, et al.
Ophthalmology|July 8, 2010
C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progressionLuba Robman, Paul N Baird, Peter N Dimitrov, et al.
Investigative Ophthalmology & Visual Science|January 4, 2008
Measuring rod and cone dynamics in age-related maculopathyPeter N Dimitrov, Robyn H Guymer, Andrew J Zele, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 13, 2006
Development of cataract and associated risk factors: the Visual Impairment ProjectBickol N Mukesh, Anhchuong Le, Peter N Dimitrov, et al.
Investigative Ophthalmology & Visual Science|February 1, 2014
Assessing residual visual function in severe vision lossLauren N Ayton, Nicholas V Apollo, Mary Varsamidis, et al.
Clinical & Experimental Ophthalmology|December 4, 2003
Iris colour, ethnic origin and progression of age-related macular degenerationCaroline M Nicolas, Luba D Robman, Gabriella Tikellis, et al.
Clinical Interventions in Aging|November 6, 2008
Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS)Robyn H Guymer, Peter N Dimitrov, Mary Varsamidis, et al.
Ophthalmology|June 5, 2004
Five-year incidence of age-related maculopathy: the Visual Impairment ProjectBickol N Mukesh, Peter N Dimitrov, Sophia Leikin, et al.
Investigative Ophthalmology & Visual Science|October 18, 2011
Visual function tests as potential biomarkers in age-related macular degenerationPeter N Dimitrov, Liubov D Robman, Mary Varsamidis, et al.
Pageof 2